{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:41:31Z","timestamp":1791308491966,"version":"4.3.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ymgme.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:27:35Z","timestamp":1536125255000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Development and clinical consequences of white matter lesions in Fabry disease: a systematic review"],"prefix":"10.1016","volume":"125","author":[{"given":"Simon","family":"K\u00f6rver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-7578","authenticated-orcid":false,"given":"Magda","family":"Vergouwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0005","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical fabry disease: A multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0015","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0020","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","article-title":"White matter lesion severity in male and female patients with Fabry disease","volume":"65","author":"Fellgiebel","year":"2005","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.ymgme.2018.08.014_bb0025","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1212\/WNL.0000000000002673","article-title":"Determinants of white matter hyperintensity burden in patients with Fabry disease","volume":"86","author":"Rost","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0030","first-page":"125","article-title":"The role of MRI in the diagnosis of multiple sclerosis","volume":"98","author":"Traboulsee","year":"2006","journal-title":"Adv. Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2018.08.014_bb0035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000343049.00540.c8","article-title":"Invited Article: An MRI-based approach to the diagnosis of white matter disorders","volume":"72","author":"Schiffmann","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","article-title":"Cerebrovascular involvement in Fabry disease: current status of knowledge","volume":"46","author":"Kolodny","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The prisma statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0055","author":"Covidence systematic review software"},{"issue":"7","key":"10.1016\/j.ymgme.2018.08.014_bb0060","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.clinph.2013.02.005","article-title":"Primary motor cortex hyperexcitability in Fabry's disease","volume":"124","author":"Ortu","year":"2013","journal-title":"Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2412051122","article-title":"Subcortical damage and cortical functional changes in men and women with Fabry disease: a multifaceted MR study","volume":"241","author":"Gavazzi","year":"2006","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000369293","article-title":"Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease","volume":"38","author":"Fellgiebel","year":"2014","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2018.08.014_bb0075","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.52.8.1663","article-title":"Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study","volume":"52","author":"Tedeschi","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2377-2-4","article-title":"Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.014_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in \u2018prior\u2019 selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"Moore","year":"2003","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0090","first-page":"916","article-title":"T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease","volume":"24","author":"Takanashi","year":"2003","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","article-title":"CNS involvement in Fabry disease: clinical and imaging studies before and after 12\u202fmonths of enzyme replacement therapy","volume":"27","author":"Jardim","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00415-005-0020-z","article-title":"Diffuse structural and metabolic brain changes in Fabry disease","volume":"253","author":"Marino","year":"2006","journal-title":"J. Neurol."},{"issue":"451","key":"10.1016\/j.ymgme.2018.08.014_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.2006.tb02391.x","article-title":"Magnetic resonance imaging changes in Fabry disease","volume":"95","author":"Ginsberg","year":"2006","journal-title":"Acta Paediatr. Suppl."},{"issue":"7","key":"10.1016\/j.ymgme.2018.08.014_bb0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1445-5994.2007.01366.x","article-title":"Neurology of Fabry disease","volume":"37","author":"Low","year":"2007","journal-title":"Intern. Med. J."},{"issue":"11","key":"10.1016\/j.ymgme.2018.08.014_bb0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","article-title":"Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study","volume":"79","author":"Buechner","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00415-008-0786-x","article-title":"The pulvinar sign: frequency and clinical correlations in Fabry disease","volume":"255","author":"Burlina","year":"2008","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2018.08.014_bb0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2018.08.014_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.03.020","article-title":"Brain MRI findings in patients with Fabry disease","volume":"305","author":"Reisin","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060304","article-title":"Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy","volume":"8","author":"Duning","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00234-012-1131-8","article-title":"Diffusion tensor imaging and brain volumetry in Fabry disease patients","volume":"55","author":"Paavilainen","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-8-47","article-title":"Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain","volume":"8","author":"Rombach","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"Borgwardt","year":"2013","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087054","article-title":"Increased Arterial Diameters in the Posterior Cerebral Circulation in Men with Fabry Disease","volume":"9","author":"\u00dc\u00e7eyler","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.014_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143940","article-title":"Positron emission tomography and magnetic resonance imaging of the brain in fabry disease: a nationwide, long-time, Prospective Follow-Up","volume":"10","author":"Korsholm","year":"2015","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0165","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.019","article-title":"Characteristics of cerebral microbleeds in patients with fabry disease","volume":"25","author":"Kono","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12883-017-0810-9","article-title":"A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4\u202f+\u202f919G\u202f>\u202fA mutation","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00234-017-1829-8","article-title":"Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis","volume":"59","author":"Cocozza","year":"2017","journal-title":"Neuroradiology"},{"issue":"19","key":"10.1016\/j.ymgme.2018.08.014_bb0180","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.0000000000003913","article-title":"Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study","volume":"88","author":"Cocozza","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000337906","article-title":"Functional transcranial Doppler: presymptomatic changes in Fabry disease","volume":"67","author":"Azevedo","year":"2012","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0190","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cge.12585","article-title":"Fabry disease in a geriatric population","volume":"88","author":"Barbey","year":"2015","journal-title":"Clin. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","article-title":"Diagnostic utility of different MRI and MR angiography measures in Fabry disease","volume":"72","author":"Fellgiebel","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ymgme.2018.08.014_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137603","article-title":"Eight-year follow-up of neuropsychiatric symptoms and brain structural changes in fabry disease","volume":"10","author":"Lelieveld","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-011-9390-9","article-title":"Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease","volume":"35","author":"Fellgiebel","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"13","key":"10.1016\/j.ymgme.2018.08.014_bb0215","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"issue":"3b","key":"10.1016\/j.ymgme.2018.08.014_bb0220","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S0004-282X2006000500002","article-title":"White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up","volume":"64","author":"Jardim","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"issue":"439","key":"10.1016\/j.ymgme.2018.08.014_bb0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1651-2227.2002.tb03114.x","article-title":"Elevated CNS average diffusion constant in Fabry disease","volume":"91","author":"Moore","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.014_bb0230","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00415-006-0118-y","article-title":"Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study","volume":"253","author":"Fellgiebel","year":"2006","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0235","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hbm.23949","article-title":"Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations","volume":"39","author":"Cocozza","year":"2018","journal-title":"Hum. Brain Mapp."},{"issue":"9","key":"10.1016\/j.ymgme.2018.08.014_bb0240","first-page":"964","article-title":"Voxel based analyses of diffusion tensor imaging in Fabry disease. Journal of Neurology, Neurosurgery &amp","volume":"78","author":"Albrecht","year":"2007","journal-title":"Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2018.08.014_bb0245","first-page":"143","article-title":"Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease","volume":"130","author":"Ries","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1468-1331.2010.03155.x","article-title":"Neuropsychiatric symptoms and brain structural alterations in Fabry disease","volume":"18","author":"Schermuly","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2018.08.014_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047805","article-title":"Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome","volume":"7","author":"Rombach","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.014_bb0260","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","article-title":"Effect of genetic modifiers on cerebral lesions in Fabry disease","volume":"64","author":"Altarescu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0265","unstructured":"Ginsberg, L., Nervous system manifestations of Fabry disease: data from FOS \u2013 the Fabry Outcome Survey, in Fabry Disease: Perspectives from 5\u202fYears of FOS, A. Mehta, M. Beck, and G. Sunder-Plassmann, Editors Oxford PharmaGenesis: Oxford."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0270","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ymgme.2010.11.098","article-title":"MRI Findings in Anderson- Fabry disease(AFD)","volume":"102","author":"Mendes","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0275","series-title":"49th ERA-EDTA Congress","first-page":"ii426","article-title":"Characteristics of clinical manifestations in Chinese Fabry patients","author":"Ouyang","year":"2012"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0280","first-page":"459","article-title":"Fabry disease brain MRI findings in adults and children","author":"Pablo","year":"2014","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0285","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.ymgme.2008.11.129","article-title":"Fabry disease: Correlation of progression of white matter disease and severity of neurological manifestations with the pulvinar sign","author":"Shankar","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0290","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ymgme.2014.12.163","article-title":"\u201cNight, night, sleep tight?\u201d: Sleep disorders in Fabry disease, recognizing an overlooked feature of a complex lysosomal disorder","volume":"114","author":"Lourenco","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0295","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ymgme.2011.11.069","article-title":"Multiparametric 3.0 Tesla MRI of the Brain in Fabry Disease","volume":"105","author":"Hanson","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0300","first-page":"S44","article-title":"Evaluation of plasma globotriaosylsphingosine in patients with anderson-fabry disease in Brazil on enzyme replacement therapy with Agalsidase Alfa","volume":"105","author":"Lourenco","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0305","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jns.2013.07.734","article-title":"Brain MRI findings in Fabry Disease","volume":"333","author":"Marchesoni","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0310","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5\u202fT in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0320","doi-asserted-by":"crossref","unstructured":"Bammer, R., Basic principles of diffusion-weighted imaging. Eur. J. Radiol. 45(3): p. 169\u2013184.","DOI":"10.1016\/S0720-048X(02)00303-0"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnins.2013.00031","article-title":"A hitchhiker's guide to diffusion tensor imaging","volume":"7","author":"Soares","year":"2013","journal-title":"Front. Neurosci."},{"issue":"455","key":"10.1016\/j.ymgme.2018.08.014_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.2007.00203.x","article-title":"Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging","volume":"96","author":"Fellgiebel","year":"2007","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jnnp.70.1.9","article-title":"Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study","volume":"70","author":"de Leeuw","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.014_bb0340","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/YCO.0b013e3282f945d5","article-title":"White matter hyperintensities in mid-adult life","volume":"21","author":"Sachdev","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.014_bb0345","first-page":"292","article-title":"White matter disease as a biomarker for long-term cerebrovascular disease and dementia","volume":"16","author":"Chutinet","year":"2014","journal-title":"Curr. Treat. Opt. Cardiovas. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.014_bb0350","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/STROKEAHA.107.493593","article-title":"Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS)","volume":"38","author":"Khatri","year":"2007","journal-title":"Stroke"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.08.014_bb0355","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000051182","article-title":"Pathophysiologic mechanisms in the development of age-related white matter changes of the brain","volume":"9","author":"Fazekas","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0360","doi-asserted-by":"crossref","unstructured":"Shim, Y.S., et al., Pathological correlates of white matter hyperintensities on MRI. Dement. Geriatr. Cogn. Disord., 2015. 39(0): p. 92\u2013104.","DOI":"10.1159\/000366411"},{"key":"10.1016\/j.ymgme.2018.08.014_bb0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0370","unstructured":"U.S. National Library of Medicine. Clinicaltrials.gov Database. [2018, May 14]; Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=Fabry+Disease&term=&cntry=&state=&city=&dist=."},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.014_bb0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/svn-2016-000035","article-title":"Update on cerebral small vessel disease: a dynamic whole-brain disease","volume":"1","author":"Shi","year":"2016","journal-title":"Stroke Vascular Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2018.08.014_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182379","article-title":"Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors","volume":"12","author":"Arends","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0385","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: Current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0390","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.014_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bpa.12219","article-title":"Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study","volume":"25","author":"Wharton","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0400","doi-asserted-by":"crossref","unstructured":"Schiffmann, R., et al., Pathological findings in a patient with Fabry disease who died after 2.5\u202fyears of enzyme replacement. Virchows Archiv: an international journal of pathology, 2006. 448(3): p. 337\u2013343.","DOI":"10.1007\/s00428-005-0089-x"},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.014_bb0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00697017","article-title":"Neuropathological and biochemical studies in Fabry's disease","volume":"30","author":"Tabira","year":"1974","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.014_bb0410","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","article-title":"An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia","volume":"28","author":"Okeda","year":"2008","journal-title":"Neuropathology"},{"issue":"8","key":"10.1016\/j.ymgme.2018.08.014_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071894","article-title":"Fabry Disease \u2013 Underestimated in the Differential Diagnosis of Multiple Sclerosis?","volume":"8","author":"B\u00f6ttcher","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ymgme.2018.08.014_bb0420","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1742-1241.2009.02115.x","article-title":"Aseptic meningitis and ischaemic stroke in Fabry disease","volume":"63","author":"Lidove","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ymgme.2018.08.014_bb0425","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2051-5960-2-20","article-title":"Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice","volume":"2","author":"Nelson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.014_bb0430","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: A scientific statement for healthcare professionals from the american heart association\/american stroke association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218304736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218304736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:21:53Z","timestamp":1761088913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218304736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1096719218304736"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and clinical consequences of white matter lesions in Fabry disease: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}